Taro Pharmaceutical Industries Ltd. (NYSE:TARO – Get Rating)’s share price hit a new 52-week low during mid-day trading on Friday . The stock traded as low as $27.50 and last traded at $27.67, with a volume of 7150 shares. The stock had previously closed at $28.02.
Wall Street Analyst Weigh In
Several research analysts recently issued reports on TARO shares. StockNews.com cut shares of Taro Pharmaceutical Industries from a “buy” rating to a “hold” rating in a report on Monday, October 31st. HC Wainwright cut their price objective on shares of Taro Pharmaceutical Industries from $73.00 to $54.00 and set a “buy” rating for the company in a report on Monday, August 15th.
Taro Pharmaceutical Industries Stock Performance
The business’s 50 day moving average price is $30.27 and its 200-day moving average price is $34.08. The firm has a market capitalization of $1.04 billion, a PE ratio of 15.99 and a beta of 0.65.
Institutional Investors Weigh In On Taro Pharmaceutical Industries
Taro Pharmaceutical Industries Company Profile
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products.
- Get a free copy of the StockNews.com research report on Taro Pharmaceutical Industries (TARO)
- MarketBeat: Week in Review 11/14 – 11/18
- Target’s Double Bottom Might Have Just Been Confirmed
- How High Can the Fed Go? How to Trade it
- Does ASML’s November Rally Have Staying Power?
- Verra Mobility Stock Has Returned Back to the Station
Receive News & Ratings for Taro Pharmaceutical Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Taro Pharmaceutical Industries and related companies with MarketBeat.com's FREE daily email newsletter.